View Older Stories View More Recent Stories

Jan 25, 2024 08:00AM Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia
Jan 23, 2024 08:02AM Scholar Rock (SRRK) Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
Jan 23, 2024 08:00AM Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
Jan 12, 2024 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 4, 2024 08:00AM Scholar Rock Provides Corporate Update and Highlights Priorities for 2024
Dec 19, 2023 08:00AM Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Dec 15, 2023 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 17, 2023 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2023 07:15AM Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress
Nov 3, 2023 04:01PM Scholar Rock (SRRK) Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients
Nov 3, 2023 04:00PM Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
Nov 2, 2023 08:00AM Scholar Rock to Participate in Upcoming Investor Conferences
Oct 23, 2023 08:00AM Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023
Oct 19, 2023 08:00AM Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting
Sep 19, 2023 08:00AM Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial
Sep 15, 2023 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 18, 2023 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 9, 2023 04:15PM Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress
Jul 13, 2023 08:00AM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 30, 2023 11:00AM New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy
Jun 15, 2023 08:00AM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 1, 2023 04:05PM Scholar Rock to Present at the Jefferies Healthcare Conference
May 10, 2023 08:00AM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 9, 2023 07:30AM Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress
May 8, 2023 08:00AM Scholar Rock to Present New Data Evaluating Apitegromab at 36 Months from the Phase 2 TOPAZ trial at the 2023 Annual Cure SMA Conference
Apr 12, 2023 08:00AM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 10, 2023 04:06PM Scholar Rock Holding (SRRK) Announces the Addition of Richard Brudnick to Its Board of Directors
Apr 10, 2023 04:05PM Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors
Mar 15, 2023 08:00AM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 7, 2023 07:00AM Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress
Mar 1, 2023 08:00AM Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Feb 27, 2023 08:00AM Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference
Feb 17, 2023 08:00AM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 6, 2023 08:00AM Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
Jan 9, 2023 08:07AM Scholar Rock Holding Corp. (SRRK) Provides Corporate Update and Highlights Priorities for 2023
Jan 9, 2023 08:00AM Scholar Rock Provides Corporate Update and Highlights Priorities for 2023
Jan 3, 2023 08:00AM Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference
Nov 15, 2022 08:00AM Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 14, 2022 08:00AM Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress
Nov 10, 2022 09:03AM Scholar Rock Holding Corp. (SRRK) Says Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy
Nov 10, 2022 09:00AM Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy
Nov 9, 2022 08:03AM Scholar Rock Holding (SRRK) Appoints Jing L. Marantz as Chief Medical Officer
Nov 9, 2022 08:00AM Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer
Nov 8, 2022 08:00AM Scholar Rock to Participate in Upcoming Investor Conferences
Oct 24, 2022 05:51AM Scholar Rock (SRRK) Reports Strong New 24-month Data from Phase 2 TOPAZ Data
Oct 22, 2022 07:00AM New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Quality-of-Life Measures Over 24 Months with Apitegromab for Nonambulatory Patients with Types 2 and 3 SMA
Oct 6, 2022 08:00AM Scholar Rock to Present Data from the Phase 1 DRAGON trial at the SITC 37th Annual Meeting
Oct 4, 2022 08:00AM Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
Sep 22, 2022 04:15PM Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sep 20, 2022 07:03AM Scholar Rock Holding Corp. (SRRK) Appoints Jay Backstrom as CEO
View More Recent Stories View Older Stories